Ligand validation:7T0U

E3I: 3-chloro-5-{7-[2-({5-chloro-2-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-4-yl}amino)-2-oxoethyl]-3-methyl-4-oxo-2-(trifluoromethyl)-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl}-2-hydroxybenzamide

E3I is a Ligand Of Interest in 7T0U designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7T0U_E3I_D_201	96%	16%	0.072	0.982	1.96	1.71	8	14	0	0	100%	0.96
7T0U_E3I_B_201	94%	16%	0.082	0.982	2.1	1.62	11	12	0	0	100%	0.92
7T0U_E3I_A_204	93%	17%	0.082	0.977	1.91	1.67	10	11	0	0	100%	0.96
7T0U_E3I_C_202	91%	11%	0.094	0.981	2.18	1.98	15	14	0	0	100%	0.89

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.